Privia Health Group Inc

For the period ended Dec 31, 2023. Filed Feb 27, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

PRVA$24.54+0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(in thousands, except share and per share data)

	For the Years Ended December 31,
	2023	2022	2021
Revenue	$1,657,737	$1,356,660	$966,220
Operating expenses:
Provider expense	1,298,573	1,051,040	727,827
Cost of platform	197,663	170,838	174,731
Sales and marketing	24,732	19,741	22,750
General and administrative	109,587	129,592	255,884
Depreciation and amortization	6,533	4,571	2,464
Total operating expenses	1,637,088	1,375,782	1,183,656
Operating income (loss)	20,649	(19,122)	(217,436)
Interest (income) expense, net	(8,372)	(542)	1,070
Income (loss) before provision for (benefit from) income taxes	29,021	(18,580)	(218,506)
Provision for (benefit from) income taxes	7,993	(6,516)	(27,857)
Net income (loss)	21,028	(12,064)	(190,649)
Less: Loss attributable to non-controlling interests	(2,051)	(3,479)	(2,419)
Net income (loss) income attributable to Privia Health Group, Inc.	$23,079	$(8,585)	$(188,230)
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders – basic	$0.20	$(0.08)	$(1.83)
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders – diluted	$0.19	$(0.08)	$(1.83)
Weighted average common shares outstanding – basic	116,731,406	110,695,266	102,952,370
Weighted average common shares outstanding – diluted	124,686,067	110,695,266	102,952,370

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.